Diabetes Care · 2009 · 82 citations · 23 references
MedicineNeurologySurgeryDiabetologyNeuropathic Foot DisordersNeuropathologyAmputation PreventionDiabetes MellitusDiabetic Foot DiseaseDiabetic Foot UlcerationDiabetic NeuropathyPeripheral Neuropathy EvaluationCardiovascular Risk StratificationDiabetes DurationDiabetic Foot DisordersDiabetic Foot Risk AssessmentDiabetic Neuropathy AssessmentHuman Vibration PerceptionVibration Perception LossVibration Perception Thresholds
OBJECTIVE: Diabetic large-nerve fiber dysfunction, as measured by vibration perception threshold (VPT), predicts foot ulceration, amputation, and mortality. Thus, determination of modifiable risk factors is of great clinical importance. RESEARCH DESIGN AND METHODS: We assessed 1,407 patients with type 1 diabetes and a normal VPT participating in the EURODIAB Prospective Complications Study, at baseline mean +/- SD age of 32.7 +/- 10.2 years with diabetes duration of 14.7 +/- 9.3 years and follow-up of 7.3 +/- 0.6 years. VPT was measured using biothesiometry on the right big toe and medial malleolus. An abnormal result was defined as >2 SD from the predicted mean for the patient s age. RESULTS: An abnormal VPT was associated with an increased incidence of gangrene, amputation, foot ulceration, leg bypass or angioplasty, and mortality (P < OR = 0.02). The incidence of abnormal VPT was 24% over the 7.3-year follow-up. Duration of diabetes and A1C significantly influenced the incidence of abnormal VPT (P < 0.0001). After correction for these, established risk factors for cardiovascular disease (CVD), including male sex (P = 0.0004), hypertension (P < 0.0001), total cholesterol (P = 0.002), LDL cholesterol (P = 0.01), smoking (P < 0.0001), weight (P < 0.0001), and diabetes complications (retinopathy [P = 0.0001], nephropathy [P = 0.01], and autonomic neuropathy [P = 0.001]), were all found to be significant risk factors. A previous history of CVD doubled the incidence of abnormal VPT. CONCLUSIONS: This prospective study indicates that cardiovascular risk factors predict development of large-fiber dysfunction, which may account for the high mortality rate in patients with an abnormal VPT, and emphasizes the importance of early determination of VPT to detect subclinical neuropathy and to address cardiovascular risk factors.
23
Vascular Risk Factors and Diabetic Neuropathy
Solomon Tesfaye, Nish Chaturvedi, Simon E.M Eaton et al. · New England Journal of Medicine · 2005 · 1.3K citations · Full text
The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.
Adam Gordois, Paul Scuffham, Arran Shearer et al. · Diabetes Care · 2003 · 736 citations · Full text
Simple Screening Tests for Peripheral Neuropathy in the Diabetes Clinic
Bruce A. Perkins, David O. Olaleye, Bernard Zinman et al. · Diabetes Care · 2001 · 580 citations